Agnieszka Harazin-Lechowska

Years Active: 2021-2023
Publications (10 Years): 3

This page only lists publications with an associated author ORCID identifier.

Publications

Ewelina Madej, Anna A Brożyna, Agnieszka Adamczyk, Norbert Wronski, Agnieszka Harazin-Lechowska, Anna Muzyk, Krzysztof Makuch, Michał Markiewicz, Janusz Rys, Agnieszka Wolnicka-Glubisz
Vemurafenib and Dabrafenib Downregulates RIPK4 Level. Cancers 15 (3) (2023)
Ewelina Madej, Anna A Brożyna, Agnieszka Adamczyk, Norbert Wronski, Agnieszka Harazin-Lechowska, Anna Muzyk, Krzysztof Makuch, Michał Markiewicz, Janusz Rys, Agnieszka Wolnicka-Glubisz
Vemurafenib and Dabrafenib Downregulates RIPK4 Level. Cancers 15 (3) (2023)
Lorissa I McDougall, Ryan M Powell, Magdalena Ratajska, Chiemi F Lynch-Sutherland, Sultana Mehbuba Hossain, George A R Wiggins, Agnieszka Harazin-Lechowska, Bozena Cybulska-Stopa, Jyoti Motwani, Erin C Macaulay, Glen Reid, Logan C Walker, Janusz Ryś, Michael R Eccles
Differential Expression of BARD1 Isoforms in Melanoma. Genes 12 (2) (2021)

Agnieszka Harazin-Lechowska.css-eqlu8i{font-size:small;padding-left:4px;}